HomeDrug Discovery and Development

Drug Discovery and Development

Addressing the Long-Term Impact of COVID

StemCyte has officially announced a significant breakthrough in its Phase IIa clinical trial of HPC, Cord Blood (HPC, CB) for treating Post-COVID Syndrome (Long...

Solving solubilization: overcoming challenges in the formulation development of oral solid dosage forms

For drug developers working on oral solid dosage drug projects, solubility, and therefore bioavailability, is a significant challenge. At present, poor water solubility impacts...

Advancing Animal-Free Organoid Models for Drug Discovery

There is an increasing drive within the pharmaceutical and personal care communities to reduce, if not eliminate, the use of animals in the testing...

Expanding Treatment Options for a Deadly Medical Condition

The brilliance of a human life experience can be put down to a host of different factors, and yet none would deserve the honor...

An Industry-First Solution to Tackle the Growing Hypertension Issue

The US Food and Drug Administration has formally approved Merck’s WINREVAIR therapeutic for the treatment of adults with pulmonary arterial hypertension (PAH). Understood to...

Hot Topics